Search

everythinglearnresearchcommunity

for

Search:↓

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Physical activity, height, and smoking affect prostate cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Flutamide rarely causes liver toxicity in prostate cancer patients.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Certain natural compounds called terpenes may help prevent prostate cancer.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride treats hair loss and reduces prostate cancer risk.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.